Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03720756 · ClinicalTrials.gov registry record · NA

Effect of a Nickel Free Diet and Nickel Sensitization on GERD Patients.

A NA study, sponsored by West Virginia University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03720756: Completed NA study, sponsored by West Virginia University.

NCT03720756 is a NA study that has completed, run by West Virginia University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03720756, a NA study, has completed, sponsored by West Virginia University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

There is little evidence on the effect of a nickel-free diet on gastroesophageal reflux disease (GERD). We hope to determine if a nickel-free diet improves GERD symptoms in patients with a nickel allergy by having patients complete a questionnaire on their GERD symptoms before and after initiation of 8 weeks on a nickel-free diet.

Primary Outcome

questionnaire to assess severity of GERD. Total Score: Calculated by summing the individual scores to questions 1-12. Greatest possible score (worst symptoms) = 60; Lowest possible score (no symptoms) = 0. For the purposes of our study, a score of 13 or above is considered symptomatic for GERD.

Interventions

  • OTHER Nickel-free diet

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-01-03
Est. Completion 2020-02-20
Phase NA
West Virginia University

122 total trials

What the finished NCT03720756 record still lists

NCT03720756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Nickel-free diet is the first listed.

NCT03720756 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03720756 about?

NCT03720756 is a clinical study titled "Effect of a Nickel Free Diet and Nickel Sensitization on GERD Patients.". There is little evidence on the effect of a nickel-free diet on gastroesophageal reflux disease (GERD). We hope to determine if a nickel-free diet improves GERD symptoms in patients with a nickel allergy by having patients complete a questionnaire on their GERD symptoms before and after initiation o...

What is the current status of trial NCT03720756?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-01-03. Estimated completion is 2020-02-20.

What interventions are being tested in trial NCT03720756?

The interventions under investigation include: Nickel-free diet (OTHER).

Who is sponsoring clinical trial NCT03720756?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03720756's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03720756, the US trial registry maintained by the National Library of Medicine. NCT03720756 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.